Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Donata Paternicò"'
Autor:
Rosa Manenti, Roberto Gasparotti, Alessandro Padovani, Orazio Zanetti, Barbara Borroni, Michela Petesi, Enrico Premi, Donata Paternicò, Maura Cosseddu, Maria Cotelli, Michela Brambilla
Publikováno v:
Europe PubMed Central
Agrammatic variant primary progressive aphasia is a neurodegenerative disorder specifically characterized by language deficits. A recent study has demonstrated a beneficial effect of transcranial direct current stimulation (tDCS) in combination with
Autor:
Alberto Benussi, Stefano Gazzina, Valentina Dell'Era, Silvana Archetti, Enrico Premi, Donata Paternicò, Barbara Borroni, Maura Cosseddu, Antonella Alberici, Alessandro Padovani, Roberto Gasparotti, Viviana Cristillo
Frontotemporal dementia (FTD) is characterized by behavioural and language impairment, accompanied by atrophic changes in fronto-temporo-insular cortices. In the presymptomatic phases of genetic FTD, subtle or no volumetric changes have been reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d31518dd0b720a0dc685ce8917cd6bc
http://hdl.handle.net/11379/501913
http://hdl.handle.net/11379/501913
Autor:
Silvana Archetti, Enrico Premi, Roberto Gasparotti, Maura Cosseddu, Antonella Alberici, Maria Cotelli, Elisa Bonomi, Stefano Gazzina, Anna Micheli, Donata Paternicò, Marta Manes, Marinella Turla, Alessandro Padovani, Barbara Borroni
Publikováno v:
Scientific Reports
Variations within genes associated with dyslexia result in a language network vulnerability, and in patients with Frontotemporal Dementia (FTD), language disturbances represent a disease core feature. Here we explored whether variations within three
Autor:
Alessandro Padovani, Barbara Borroni, Enrico Premi, Antonella Alberici, Roberto Gasparotti, Vera Gualeni, Elisa Bonomi, Silvana Archetti, Donata Paternicò
Publikováno v:
Neurology: Genetics
Objective: In this study, we evaluated whether variations within genes specifically associated with dyslexia, namely KIAA0319 , DCDC2 , and CNTNAP2 , were associated with greater damage of language-related regions in patients with frontotemporal deme
Autor:
Giuliano Binetti, Luisa Benussi, Alberto Orlandini, Donata Paternicò, Silvia Magnaldi, Milena Cobelli, Roberta Ghidoni, Michela Pievani, Giovanni B. Frisoni
Publikováno v:
Alzheimer's and Dementia, Vol. 10, No 5 Suppl (2014) pp. S354-S363.e1
Background To investigate the patterns of brain atrophy, white matter (WM) tract changes, and functional connectivity (FC) abnormalities in asymptomatic granulin ( GRN ) mutation carriers. Methods Ten cognitively normal subjects (five mutation carrie
Publikováno v:
Journal of Alzheimer's Disease & Parkinsonism.
Mirror neurons have been localized in several locations, including the inferior parietal lobule (IPL). Increase of EEG alpha3/alpha2 frequency ratio has been detected in mild cognitive impairment (MCI) subjects who will convert in Alzheimer’s disea
Publikováno v:
Journal of Neurology & Neurophysiology.
Background: Reliable biomarkers are the new frontier for an early diagnosis of Alzheimer's disease and to monitor therapeutic options Objective: Volume reduction in temporo-parietal network is associated to mild cognitive impairment (MCI) due to Alzh
Publikováno v:
Journal of Neurology & Neurophysiology.
Background: The nucleus accumbens (NAc) has been associated with impulsive behavior in subjects with early cognitive impairment; grey matter (GM) changes of basal ganglia have been demonstrated to be involved in Alzheimer’s disease (AD). Moreover,
Autor:
Valeria Drago, Roberta Zanardini, Manuela Baronio, Luisella Bocchio-Chiavetto, Laura Pedrini, Giovanni Amicucci, Samantha Galluzzi, Donata Paternicò, Giovanni B. Frisoni
Publikováno v:
Europe PubMed Central
BACKGROUND: Low amyloid β42 (Aβ42) and high total tau and phosphorylated tau (p-tau) concentrations in the cerebrospinal fluid (CSF) are biomarkers of Alzheimer's disease (AD), reflecting brain deposition of amyloid plaques and tangles. Age and apo
Autor:
Susanne Ostrowitzki, Cristina Scarpazza, Olivier Blin, Donata Paternicò, Elaine A. Irving, Giovanni B. Frisoni, Marco Lorenzi, Michael C. Donohue
Clinical trials of disease modifying drugs for Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) might benefit from enrichment with true AD cases. Four hundred five MCI patients (143 converters and 262 nonconverters to AD with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987c502ab040885a9ce3bfcf9de33f68
https://hal.inria.fr/inria-00616109
https://hal.inria.fr/inria-00616109